- Filed
- Jan 10, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2022 · Mar 31, 2022 | 36.6M sh |
| Cash And Equivalents | Q1 2022 · Mar 31, 2022 | $416 |
| Cash And Equivalents | Q1 2022 · Dec 31, 2021 | $1.16K |
| Cash And Equivalents | Q1 2022 · Mar 31, 2021 | $852 |
| Cash And Equivalents | Q1 2022 · Dec 31, 2020 | $1.01K |
| Current Liabilities | Q1 2022 · Mar 31, 2022 | $281.3K |
| Current Liabilities | Q1 2022 · Dec 31, 2021 | $280.3K |
| Total Liabilities | Q1 2022 · Mar 31, 2022 | $281.3K |
| Total Liabilities | Q1 2022 · Dec 31, 2021 | $280.3K |
| Total Assets | Q1 2022 · Mar 31, 2022 | $416 |
| Total Assets | Q1 2022 · Dec 31, 2021 | $1.16K |
| Sga Expense | Q1 2022 · Mar 31, 2022 | $1.59K |
| Sga Expense | Q1 2022 · Mar 31, 2021 | $1.7K |
| Operating Cash Flow | Q1 2022 · Mar 31, 2021 | −$8.16K |
| Stockholders Equity restated | Q1 2022 · Mar 31, 2021 | −$245.45K |
| Stockholders Equity | Q1 2022 · Dec 31, 2020 | −$235.79K |
| Net Income | Q1 2022 · Mar 31, 2021 | −$9.66K |
| Operating Income | Q1 2022 · Mar 31, 2021 | −$9.66K |
| Revenue | Q1 2022 · Mar 31, 2021 | $0 |